Bulk pricing is available! Click here to learn more.
TheAnswerPage Certified Medical Marijuana 2-hr Course For Ohio Healthcare Providers with 2 Additional CME Courses
This Comprehensive Medical Marijuana Curriculum is certified by the Ohio State Medical Association and meets the education requirements set forth by the State Medical Board of Ohio. Treatment protocols for the qualifying medical conditions as defined by the Ohio Revised Code Section 3796.01 are discussed.
This purchase option includes the following courses
- TheAnswerPage Certified Medical Marijuana 2-hr Course for Ohio Healthcare Providers – 2 credits
- The Health Effects of Marijuana and Cannabinoids in Epilepsy – 0.5 credits (no APA credits are offered for this module)
- Legal and Medical Considerations in the Recommendation of Medical Marijuana – 1.5 credits
Subscribers can complete the curriculum and refer back to the content at any point during their 12-month subscription period.
Content provides Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE), American Association of Nurse Practitioners (AANP), American Nurses Credentialing Center (ANCC), American Psychological Association (APA) credits, and American General Dentistry (AGD) PACE credits.
TheAnswerPage Certified Medical Marijuana 2-hr Course for Ohio Healthcare Providers is the “Comprehensive Medical Marijuana Curriculum” along with the supplement entitled “Ohio’s Medical Marijuana Control Program Qualifying Conditions.”
This Comprehensive Medical Marijuana Curriculum is certified by the Ohio State Medical Association and fulfills the Ohio CME requirements of the Ohio Certificate to Recommend (CTR) initial application. Treatment protocols for the qualifying medical conditions as defined by the Ohio Revised Code Section 3796.01 are addressed.
Table of Contents:
Course 1: The Comprehensive Medical Marijuana Curriculum is comprised of 4 lessons:
- Lesson 1: The Endocannabinoid System and Phytocannabinoids
Lesson 1 introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant. Lesson 1 also includes an explanation of the pharmacological properties of the major and minor phytocannabinoids.
- Lesson 2: Marijuana Products, Modes of Administration and Pharmacokinetics
Lesson 2 discusses a variety of marijuana products, various modes of administration and the pharmacokinetic properties of marijuana and cannabinoid-based products.
- Lesson 3: Precautions: The Use of Cannabinoid-based Drugs in Special Patient Populations and Cannabinoid-based Drug Metabolism and Potential Cannabinoid-based Drug Interactions
Lesson 3 addresses the use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided, as well. Lesson 3 also discusses cannabinoid-based drug metabolism and potential cannabinoid-based drug interactions.
- Lesson 4: Physiologic and Cognitive Effects of Marijuana
Lesson 4 provides a detailed description of the physiologic and cognitive effects of marijuana.
Ohio Supplement: Ohio’s Medical Marijuana Control Program Qualifying Conditions is comprised of 1 lesson:
- Lesson 1: The Ohio Supplement: Ohio’s Medical Marijuana Control Program Qualifying Conditions
Lesson 1 reviews the health conditions that qualify for medical marijuana therapy in Ohio. Also, lesson 1 identifies resources for clinical practice guidelines for the diagnosis, treatment and/or management of these qualifying conditions.
Course 2: The Health Effects of Marijuana and Cannabinoids in Epilepsy is comprised of 1 lesson:
- Lesson 1: The Health Effects of Marijuana and Cannabinoids in Epilepsy
Lesson 1 describes how the endocannabinoid system may affect seizure threshold, and reviews the available research and clinical evidence for the use of marijuana or cannabinoids in the treatment of epilepsy. In addition, there is a discussion about an FDA-approved cannabis-based medicine for the treatment of Dravet syndrome and Lennox-Gastaut syndrome which are two rare and severe forms of epilepsy.
Course 3: Legal and Medical Considerations in the Recommendation of Medical Marijuana (along with Information on the Prescribing of FDA-approved Cannabinoid-based Medicines) is comprised of 3 lessons:
- Lesson 1: The Laws, The Rules and The Regulations
Lesson 1 discusses the legal issues impacting the production, distribution and use of medical marijuana. Specifically, this lesson describes the statutes, judicial decisions, and administrative efforts which have shaped the federal posture and influenced the ability of individual states to enact medical marijuana programs.
- Lesson 2: Recommending Medical Marijuana
Lesson 2 begins with a discussion of the Federation of State Medical Boards’ “Model Guidelines for the Recommendation of Marijuana in Patient Care” and then transitions into a discussion about the medical literature on the health effects of marijuana use. Specifically, the National Academies of Science, Engineering and Medicine’s 2017 publication, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research will be described in detail. Lesson 2 also addresses interpreting the results of studies that examine the effects of marijuana use.
- Lesson 3: The FDA Drug Approval Process and FDA-approved Cannabinoid-based Medicines
Lesson 3 reviews the United States Food and Drug Administration’s (FDA) drug approval process, and provides a description of cannabinoid-based medications that have been approved by the FDA.
I don’t plan on recommending marijuana…why would I take this course?
Whether or not you have any intention of recommending medical marijuana for patient care, you need to be well educated in this clinical area because your patients will be seeking your expert advice and guidance for this medication. Further, some of your patients may already be utilizing medical marijuana and you will need to be aware of its physiologic effects as well as its potential drug interactions. As such, expertise in the endocannabinoid system and medical marijuana is paramount for most doctors, pharmacists, nurses, psychologists, and other allied health professionals to remain that respected guide for their patients’ overall healthcare. And, your patients will appreciate that you chose to go the extra distance in being prepared to address their health questions related to the endocannabinoid system and the clinical aspects of medical marijuana.
Meredith Fisher-Corn, MD
Stephen B. Corn, MD
The educational design of this activity addresses the needs of physicians, nurses, nurse practitioners, pharmacists, psychologists, and dentists interested in the use of cannabinoids.
This curriculum offers up to 4 hours of ACCME , ANCC, ACPE, AANP, and AGD PACE credits. This curriculum offers up to 3.5 APA credits.
Expires May 21 , 2021. Full accreditation information is available upon purchase.
After completing this activity, the participant should be better able to:
- Describe the endocannabinoid system
- Discuss the components of the endocannabinoid system
- List some of the many functions of the endocannabinoid system
- Define cannabis
- Define marijuana
- Define hemp
- Define phytocannabinoid
- Describe some of the phytocannabinoids
- List a variety of marijuana products
- Describe various modes of marijuana administration
- Describe the pharmacokinetic profile of marijuana for several modes of administration
- Discuss the use of cannabinoid-based drugs in patients with a history of psychotic illness
- Discuss the use of cannabinoid-based drugs in patients with ischemic heart disease
- Discuss the use of cannabinoid-based drugs in patients with hepatic disease
- Discuss the use of cannabinoid-based drugs in patients with a history of drug abuse
- Discuss the use of cannabinoid-based drugs in patients with a hypersensitivity to cannabis-based products
- Discuss the use of cannabinoid-based drugs in obstetric patients
- Discuss the use of cannabinoid-based drugs in pediatric/adolescent patients
- Discuss the use of cannabinoid-based drugs in elderly patients
- List the enzymes responsible for the metabolism of three phytocannabinoids (THC, CBD and CBN)
- Identify clinically significant drug interactions that may occur with cannabinoid-based drugs
- List multiple factors that influence the physiologic and cognitive effects of marijuana
- Discuss the physiologic effects of marijuana
- Discuss the cognitive effects of marijuana
- Describe how marijuana affects CNS function
- Describe how marijuana affects appetite and metabolism
- Describe how marijuana affects gastrointestinal function
- Describe how marijuana affects cardiovascular function
- Describe how marijuana affects the reproductive system
- Describe how marijuana affects the eye
Global Contact Information
For information about the approval of this program, please contact Global at 303-395-1782 or email@example.com.
Instructions for Obtaining Credit
In order to receive credit for this activity, the participant must complete the activity, pass the posttest with a score of 70% or greater, and fill out the activity evaluation.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and The Answer Page do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Physicians interested in obtaining a certificate to recommend medical marijuana must apply to the State Medical Board of Ohio. For a detailed set of instructions, please go to: https://www.medicalmarijuana.ohio.gov/physicians and watch the video on “How to Apply for a CTR”.
NOTE: Learners must submit two certificates with the CTR application: A certificate of credit entitled “The Comprehensive Medical Marijuana Curriculum” and a certificate of completion entitled “Ohio’s Medical Marijuana Control Program Qualifying Conditions.”